The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

New cancer treatments are exploding around the world. This month 32,000 researchers from around the world convened for the 55th American Society of Clinical Oncology (ASCO) Annual Meeting to present their findings in the treatment of all cancers. There were over 5,600 new research results presented. If you have non-Hodgkins Lymphoma, here is one for your cancer:

Jason Westin, MD, on Diffuse Large B-Cell Lymphoma: Rituximab, Lenalidomide, and Ibrutinib Prior to Chemotherapy

2019 ASCO Annual Meeting

Jason Westin, MD, of The University of Texas MD Anderson Cancer Center, discusses findings of the Smart Start study on the chemotherapy-free combination of rituximab, lenalidomide, and ibrutinib in newly diagnosed diffuse large B-cell lymphoma (Abstract 7508).

ASCO is a great source of the latest news in cancer treatment.

Comments are closed.

Of Interest